The Journal of Rheumatology, Volume 35, Issue 4Journal of Rheumatology Publishing Company, 2008 |
Contents
New Developments in | 547 |
The Time Has Come to Include Assessment | 553 |
Common Polymorphisms in the Folate Pathway Predict | 562 |
Copyright | |
17 other sections not shown
Common terms and phrases
Adalimumab adverse events AIMS2 allele analysis ankylosing spondylitis Ann Rheum antibodies Arthritis Rheum assessment associated autoimmune BASDAI baseline bisphosphonates bone cartilage Caucasian cells Clin clinical trials cohort collagen compared controls correlation criteria cytokines detect diagnosis differences disease activity DMARD drugs E-mail effects ENBREL erosions etanercept evaluated factors fatigue folate followup fulvestrant function gene genetic genotype global haplotype Hospital inflammatory infliximab injection juvenile idiopathic arthritis knee levels lymphotactin markers MCID measures Medical methotrexate MTHFR osteoarthritis outcome pain Partial r² patients with RA patients with rheumatoid physician placebo polymorphisms preeclampsia proteasome protein psoriasis psoriatic arthritis Questionnaire RA patients radiographic receptor reported response rheumatoid arthritis Rheumatol Rheumatology risk sample score self-reported serum significant significantly skin symptoms Synvisc systemic lupus erythematosus Table therapy tion TLR4 treatment utility uveitis validation variables Website weeks